These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 380912)
1. Levamisole (R 12564) in the prevention of recurrent upper respiratory tract infections in children: a double-blind, placebo-controlled study. De Loore F; Heck E; Van Eygen M; Casneuf J Curr Med Res Opin; 1979; 6(2):142-7. PubMed ID: 380912 [TBL] [Abstract][Full Text] [Related]
2. A placebo controlled, double-blind evaluation of levamisole in the reduction of the frequency, duration and severity of attacks in children suffering from recurrent upper respiratory tract infections. Dils F J Int Med Res; 1979; 7(4):302-4. PubMed ID: 385400 [TBL] [Abstract][Full Text] [Related]
3. Levamisole in prevention of recurrent upper-respiratory-tract infections in children. Van Eygen M; Znamensky PY; Heck E; Raymaekers I Lancet; 1976 Feb; 1(7956):382-5. PubMed ID: 55648 [TBL] [Abstract][Full Text] [Related]
4. A double-blind pediatric evaluation of levamisole in the prevention of recurrent upper respiratory tract infections. Van Eygen M; Dils F; Gillerot J; Verschueren E Eur J Pediatr; 1979 Jun; 131(3):147-53. PubMed ID: 477676 [TBL] [Abstract][Full Text] [Related]
5. A double-blind, controlled trial of levamisole in the treatment of recurrent herpes labialis. Russell AS; Brisson E; Grace M J Infect Dis; 1978 May; 137(5):597-600. PubMed ID: 351073 [TBL] [Abstract][Full Text] [Related]
6. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections. Esposito S; Bianchini S; Bosis S; Tagliabue C; Coro I; Argentiero A; Principi N J Transl Med; 2019 Aug; 17(1):284. PubMed ID: 31443716 [TBL] [Abstract][Full Text] [Related]
7. [Administration of levamisole to children with kidney disease exacerbation caused by recurrent respiratory infections]. Prandota J; Kobylińska J; Lipowska K Pol Tyg Lek; 1989 Jul 10-17; 44(28-29):673-6. PubMed ID: 2637440 [TBL] [Abstract][Full Text] [Related]
8. Effect of levamisole on the incidence and prevalence of recurrent aphthous stomatitis. A double-blind clinical trial. Miller MF; Silvert ME; Laster LL; Green P; Ship II J Oral Pathol; 1978; 7(6):387-92. PubMed ID: 105097 [TBL] [Abstract][Full Text] [Related]
12. Double-blind study of levamisole in aphthous stomatitis. Kaplan B; Cardarelli C; Pinnell SR J Oral Pathol; 1978; 7(6):400-4. PubMed ID: 105099 [TBL] [Abstract][Full Text] [Related]
13. Levamisole in rheumatoid arthritis. Final report on a randomised double-blind study comparing a single weekly dose of levamisole with placebo. Multicentre Study Group. Ann Rheum Dis; 1982 Apr; 41(2):159-63. PubMed ID: 7041831 [TBL] [Abstract][Full Text] [Related]
14. [Prevention of infections of the respiratory tract in children with RU 41740]. Bonfils P Presse Med; 1988 Jul; 17(28):1450-2. PubMed ID: 2971185 [TBL] [Abstract][Full Text] [Related]
15. Double blind crossover trial of levamisole in recurrent aphthous ulceration. Lehner T; Wilton JM; Ivanyi L Lancet; 1976 Oct; 2(7992):926-9. PubMed ID: 62161 [TBL] [Abstract][Full Text] [Related]